SPY417.26+1.39 0.33%
DIA341.86+1.53 0.45%
IXIC14,052.34+13.58 0.10%

BRIEF-Summit Therapeutics Reports Cash, Cash Equivalents On December 31, 2020, Of $66.4 Mln Vs $63.8 Mln On December 31, 2019

· 03/17/2021 07:47
BRIEF-Summit Therapeutics Reports Cash, Cash Equivalents On December 31, 2020, Of $66.4 Mln Vs $63.8 Mln On December 31, 2019

- Summit Therapeutics Inc SMMT.O:

  • SUMMIT THERAPEUTICS REPORTS FINANCIAL RESULTS AND OPERATIONAL PROGRESS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2020

  • SUMMIT THERAPEUTICS INC - CASH AND CASH EQUIVALENTS ON DECEMBER 31, 2020, OF $66.4 MILLION COMPARED TO $63.8 MILLION ON DECEMBER 31, 2019

Source text for Eikon: ID:nGNXbjGs0L

Further company coverage: SMMT.O


((Reuters.Briefs@thomsonreuters.com;))